CL
Clover Health
CLOV · NASDAQ
$4.79 +4.59% (+$0.21)
1M -0.62%
Market Cap $2.37B
P/E Ratio -
Div. Yield -
ROE 5.38%
Bulios Fair Price
$4.48
6.5% downside
Current Price
$4.79
Undervalued Fair Value Overvalued
According to Bulios Fair Price, CLOV is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
3/9Valuation
49 /100
Fair P/B 6.31x
P/FCF 31.99x
P/S 0.96x
Growth
78 /100
Growing Book val. growth 4.72%
Rev. growth 20.62%
FCF growth N/A
Profitability
13 /100
Weak FCF margin 3.00%
Op. margin 0.74%
Gross margin 18.57%
Quality
15 /100
Poor Asset turnover 3.44x
ROA 2.55%
ROIC 4.62%
Debt
92 /100
Low Current ratio 1.50x
Debt/Equity 0.00x
Net debt/EBITDA N/A
Stability
21 /100
Unstable Profitable years 0
EPS volatility 90.56%
Beta 2.46x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about CLOV
Online
Sector
Healthcare
Industry
Medical - Healthcare Plans
CEO
Andrew Toy
Employees
724
Headquarters
Wilmington
Upcoming events
04 NOV
Earnings
Upcoming earnings report